Organic Process Research & Development 2010, 14, 1202–1208
The Continuous Catalytic Debenzylation of 1,4-Dibenzyloxybenzene with H2 in THF
Expanded with High Pressure CO2
Geoffrey R. Akien,†,‡ Jean-Christophe Legeay,†,§ Andrew Wells,⊥ and Martyn Poliakoff*,†
School of Chemistry, The UniVersity of Nottingham, UniVersity Park, Nottingham, United Kingdom NG7 2RD, and
AstraZeneca, Chemical Sciences, Loughborough, United Kingdom LE11 5RH
Abstract:
preparative supercritical fluid chromatography (SFC) versus
preparative HPLC,4 the overall energy cost for SFC was larger
than for HPLC, precisely because of the high energy costs of
cooling and heating CO2 to recycle it. When larger quantities
of organic modifiers are used, the fluid may then be termed a
gas-expanded liquid5,6 (GXL), which has improved solvent
power compared to modified scCO2, but still reduces the volume
of organic solvent required.3
One barrier to the application of GXLs in complex organic
reactions is the paucity of research on pharmaceutically relevant
molecules.6 The most obvious examples in this area include
the complexation of indomethacin with copper acetate,7 the
hydrogenation of 2-(6′-methoxy-2′-naphthyl)propenoic acid to
form (S)-naproxen,8,9 the selective hydrogenation of rac-
sertraline imine,10 and the asymmetric hydrogenation of methyl-
(Z)-R-acetamidocinnamate.11 In an attempt to rectify this
situation, this paper describes work on the O-debenzylation of
a model compound, 1,4-dibenzyloxybenzene (1a). Benzyl
groups are frequently used as protecting groups for hydroxyl
and amine moieties.12-20 Like many compounds of interest as
pharmaceutical intermediates, 1a has a relatively low solubility
in common organic solvents, and it is also symmetric, making
selective removal of only one of the benzyl groups a challenge.
Simplistically, the overall reaction probably takes place in two
The continuous debenzylation of 1,4-dibenzyloxybenzene (1a) with
H2 and supported Pd catalysts has been studied in high-
pressure CO2 + tetrahydrofuran. A range of parameters
and catalysts have been tested, with one of the most
successful results giving 86% conversion and 86% selectivity
to the monodebenzylated product, 1,4-(benzyloxy)phenol
(2a). In the absence of CO2, the reaction was unselective
with no formation of 2a. When complete debenzylation was
required, the best catalyst was 5% Pd supported on Deloxan
APII, giving quantitative yields of hydroquinone (3), the
completely debenzylated product, at temperatures as low
as 50 °C. This Deloxan-supported catalyst was also sub-
stantially active at only 30 °C.
Introduction
Continually increasing consumer and regulatory pressures
on the pharmaceutical industry are strong drivers for reduced
use of organic solvents throughout the manufacturing chain.1
One potential strategy is to replace some of the organic solvents
with supercritical fluids (SCFs),2 typically supercritical CO2
(scCO2). CO2 is attractive because of its low cost, low reactivity,
and relatively accessible critical conditions (31.1 °C and 73.8
bar). Unfortunately, scCO2 has a low polarity so is unsuitable
for dissolving the majority of pharmaceutical molecules of
interest. Indeed, in some cases these molecules are barely
soluble in the majority of common organic solvents. Adding
small quantities of ‘modifiers’, organic solvent (typically <10
mol %), to the scCO2 improves the solvent power of the fluid
significantly, thereby rendering the scCO2 more useful for a
wider range of organic intermediates, while still retaining some
of the benefits of reduced organic solvent use.3 However, it is
important to acknowledge that there is a significant energy cost
in compressing the CO2. In a recent life-cycle analysis of
(4) Van der Vorst, G.; Van Langenhove, H.; De Paep, F.; Aelterman,
W.; Dingenen, J.; Dewulf, J. Green Chem. 2009, 11, 1007–1012.
(5) Jessop, P. G.; Subramaniam, B. Chem. ReV. 2007, 107, 2666–2694.
(6) Akien, G. R.; Poliakoff, M. Green Chem. 2009, 11, 1083–1100.
(7) Warwick, B.; Dehghani, F.; Foster, N. R.; Biffin, J. R.; Regtop, H. L.
Ind. Eng. Chem. Res. 2000, 39, 4571–4579.
(8) Combes, G. B.; Dehghani, F.; Lucien, F. P.; Dillow, A. K.; Foster,
N. R. Asymmetric Catalytic Hydrogenation in CO2 Expanded Metha-
nol: An Application of Gas Anti-Solvent Reactions (GASR). In
Reaction Engineering for Pollution PreVention; Abraham, M. A.,
Hesketh, R. P., Eds.; Elsevier: Amsterdam, 2000; pp 173-181.
(9) Combes, G.; Coen, E.; Dehghani, F.; Foster, N. J. Supercrit. Fluids
2005, 36, 127–136.
(10) Clark, P.; Poliakoff, M.; Wells, A. AdV. Synth. Catal. 2007, 349, 2655–
2659.
(11) Shariati, A.; Sheldon, R. A.; Witkamp, G. J.; Peters, C. J. Green Chem.
2008, 10, 350–354.
* Author for correspondence. E-mail: martyn.poliakoff@nottingham.ac.uk.
† The University of Nottingham.
(12) Baltzly, R.; Buck, J. S. J. Am. Chem. Soc. 1943, 65, 1984–1992.
(13) Baltzly, R.; Russell, P. B. J. Am. Chem. Soc. 1950, 72, 3410–3413.
(14) Baltzly, R.; Russell, P. B. J. Am. Chem. Soc. 1953, 75, 5598–5602.
(15) Baltzly, R.; Russell, P. B. J. Am. Chem. Soc. 1954, 76, 5776–5777.
(16) Sajiki, H.; Kuno, H.; Hirota, K. Tetrahedron Lett. 1997, 38, 399–
402.
‡ Present address: Department of Biology and Chemistry, City University of
Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR.
§ Present address: Transformations Inte´gre´es de la Matie`re Renouvelable,
ESCOM-UTC, 1-Alle´e du Jean-Marie Buckmaster, 60200 Compie`gne, France.
⊥ AstraZeneca, Chemical Sciences, Loughborough, U.K. LE11 5RH.
(1) Constable, D. J. C.; Dunn, P. J.; Hayler, J. D.; Humphrey, G. R.;
Leazer, J. L.; Linderman, R. J.; Lorenz, K.; Manley, J.; Pearlman,
B. A.; Wells, A.; Zaks, A.; Zhang, T. Y. Green Chem. 2007, 9, 411–
420.
(17) Blaser, H. U.; Indolese, A.; Schnyder, A.; Steiner, H.; Studer, M. J.
Mol. Catal. A: Chem. 2001, 173, 3–18.
(18) Clayden, J.; Greeves, N.; Warren, S.; Wothers, S., Organic Chemistry,
7th ed.; Oxford University Press: Oxford, 2001.
(2) Handbook of Green Chemistry, Volume 4: Supercritical SolVents;
Leitner, W., Jessop, P. G., Eds.; Wiley-VCH: Weinheim, 2010.
(3) Wei, M.; Musie, G. T.; Busch, D. H.; Subramaniam, B. J. Am. Chem.
Soc. 2002, 124, 2513–2517.
(19) Dugger, R. W.; Ragan, J. A.; Ripin, D. H. B. Org. Process Res. DeV.
2005, 9, 253–258.
(20) Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. Org. Biomol.
Chem. 2006, 4, 2337–2347.
1202
•
Vol. 14, No. 5, 2010 / Organic Process Research & Development
10.1021/op100136g 2010 American Chemical Society
Published on Web 07/19/2010